About Us
Welcome Message from our President
I would like to thank you for taking the journey with us to discover new solutions for next generation healthcare.
My career in biomedical services includes CryoLife, one of the world’s leading medical technology companies that developed a decellularization technology to preserve human tissue for cardiac and vascular surgeries, known as the SynerGraft™ process. CryoLife completed Its IPO in February 1993 (NYSE: CRY).
Despite my experience in the biomedical field, I struggled to provide meaningful help to our 19-year-old son, Bradley Allen, who became addicted to prescribed OxyContin, and later, Suboxone resulting from a car accident. Tragically, Bradley died of an overdose in January 2014.
We started JBA Health to help other families avoid the pain and suffering we endured when a loved one has an opioid related addiction.
If you have been treating the pain associated with opioid withdrawal using the same limited tool set – medications for opioid use disorder or basic comfort meds; we believe the time has come to add a less complicated, drug free, non-addictive approach with an FDA cleared, prescription based wearable electrical nerve stimulation device.
At JBA Health, we recently introduced wearable electronic nerve stimulation devices that can reduce the pain associated with opioid withdrawal symptoms in as little as 30 minutes. This medical technology delivers personally tailored mild electrical signals attached to the skin (no needles) around the patient’s ear. The electrical signals target specific nerves that activate areas of the brain that release endorphins, which then fill the empty opioid receptors and aid in the reduction of pain associated with opioid withdrawal symptoms. Some of these devices can be worn at home or work as prescribed by their physician which allows the patient to continue their daily schedule.
I encourage you to learn more about this revolutionary electrical nerve stimulation technology by scheduling a 30-minute demo via our “Contact Us” form.
Ahead, we look forward to introducing other solutions for next generation healthcare technologies, including Acute and Chronic Non-Opioid Pain Management, Regenerative Medicine, and AI Assisted Healthcare.
Wishing you a healthy and happy long life.
Yours truly,
L. Michelle Allen
Advisory Board
SCOTT E. LUKAS, PH. D.
Professor Harvard Medical School
Scott is a leading expert on brain
research in the areas of substance abuse and neuroimaging.
His research laboratory is focused on the effects of psychoactive drugs on brain function and human behavior.
His staff is expert at using many tools such as brain electrical activity (EEG) and magnetic resonance imaging.
DAVID FIELLIN, MD
Program in Addiction Medicine Yale School of Medicine
David’s scholarly work is focused on the interface between addiction, primary care, and general healthcare settings. Has served as Principal Investigator on multiple NIH-funded research clinical trials regarding opioid dependence. Serves on the Editorial Boards of various medical journals including the Journal of Addiction Medicine and Journal of Substance Abuse Treatment.
EDWARD V. NUNES, MD
Addiction Psychiatry Columbia University Medical
Ned is an internationally recognized leader in research for the treatment of substance use disorders.
Has served as Principal Investigator on numerous clinical trials focused on the effectiveness of new treatments in real- world settings.
His research has been funded by the NIH and published in numerous medical journals including JAMA, New England Journal of Medicine, and Lancet.
New approaches for healthcare worldwide
- We provide wholesale medical technologies to high performance healthcare systems, government agencies, and physicians.
- Our technologies include wearable electrical nerve stimulation devices to manage the pain associated with opioid withdrawal.
JBA Health is focused on providing new approaches for healthcare worldwide.
- Wearable electrical nerve stimulation devices - to manage the pain associated with opioid withdrawal.
- Regenerative medicine - to repair or grow human tissue and organs in the laboratory with cell-based technologies.
- • AI assisted healthcare software - to bring about transformative change for hospitals, physicians, and patients.
Emma Stone
General Practitioner
“Fusce vitae commodo ipsum, eu ullam corper magna nam non posuere.”
Years
Already Experienced In The World of Health
Who We Serve
Healthcare Systems
Government Agencies
Physicians & Clinics
Why Choose Us
Independent Thought
We independently review technologies and make available those we believe offer the best features based on value, price, and/or performance.
Trusted Partner
We partner with clients and are proud of our outstanding client service and
support.
Integrity
We are committed to conducting our business with high integrity.